Autoplaque vs QFR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

QFR

by Medis Medical Imaging

AI Verdict

Autoplaque and QFR are adjacent AI tools for coronary assessment, differing primarily in their imaging modality and analytical focus. Autoplaque analyzes CT angiography images for plaque characterization and luminal stenosis, aiding in risk prediction. QFR, conversely, uses X-ray angiography to assess the functional significance of lesions via Quantitative Flow Ratio.

Choose Autoplaque if…

Choose Autoplaque if your primary need is a non-invasive, detailed quantitative analysis of coronary plaque burden and luminal stenoses from CT angiography images. This tool is ideal for comprehensive heart attack risk prediction and guiding early treatment strategies based on anatomical plaque characteristics.

View Autoplaque →

Choose QFR if…

Choose QFR if you require an AI-powered assessment of the functional significance of coronary lesions using X-ray angiographic images, typically within or integrated with a cath lab environment. This tool is best suited for cardiologists needing to evaluate the hemodynamic impact of a stenosis to guide interventional decisions.

View QFR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	QFR
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	On-premise (integrates into cath lab environment)
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Autoplaque

Autoplaque offers workstation-based deployment compatible with common Windows and Mac platforms, providing flexibility for clinicians. Its features include automated segmentation that is reviewable and editable, along with multiple viewing options, suggesting a user-friendly and interactive experience.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in cardiology, addressing different but equally critical aspects of coronary artery disease. Autoplaque focuses on non-invasive plaque characterization and stenosis measurement from CTA for risk prediction, while QFR provides non-invasive functional assessment from X-ray angiography for interventional decision-making.

Pricing & Value

Tie

Neither Autoplaque nor QFR disclose their pricing information in the provided facts or through web searches. This lack of transparency makes it impossible to conduct a head-to-head comparison on pricing or assess their respective value propositions.

Enterprise Readiness

Autoplaque

Autoplaque, developed by Cedars-Sinai Medical Center, a major US healthcare institution, implies robust internal development, security practices, and adherence to healthcare regulations. It also explicitly states DICOM compliance for image handling. QFR's HIPAA compliance is only noted as 'unknown (likely),' which is less definitive.

Innovation

QFR

While Autoplaque's detailed AI-powered plaque characterization from CTA is innovative for non-invasive risk assessment, QFR's ability to derive quantitative flow ratio (QFR) from standard X-ray angiography without invasive pressure wires represents a more transformative innovation in interventional cardiology by reducing procedural invasiveness.

Support & Docs

Autoplaque

Autoplaque's FDA documentation explicitly mentions the existence of a 'user manual' and the requirement for 'appropriately trained' medical professionals to use the software. This indicates a foundational level of documentation and implied support for proper usage, whereas no such information was found for QFR.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	QFR
Name	Autoplaque	QFR
Company	Cedars-Sinai Medical Center: AIM	QFR Solutions bv
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	QFR by QFR Solutions bv is an FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment.
Primary Imaging Modality	CT Angiography	X-ray Angiography
Key Analysis Focus	Quantitative analysis of atherosclerotic plaque and luminal stenoses	Quantitative Flow Ratio (QFR) assessment for functional significance

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and QFR.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities are required for Autoplaque and QFR?

Autoplaque is an AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. QFR by QFR Solutions bv is designed for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments.

What is the primary clinical focus of Autoplaque compared to QFR?

Autoplaque's primary focus is on quantitative analysis of coronary plaques and luminal stenoses, aiding in heart attack risk prediction and treatment guidance. QFR's main objective is to aid cardiologists in lesion assessment through quantitative flow ratio (QFR) analysis for functional significance.

What specific analytical capabilities do Autoplaque and QFR offer for coronary assessment?

Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses. QFR provides automatic detection and editing of vessel contours, 3D reconstruction of coronary vessel models, and Quantitative Flow Ratio (QFR) assessment for functional significance.

Are both Autoplaque and QFR cleared by the FDA?

Yes, both Autoplaque, developed by Cedars-Sinai AIM, and QFR by QFR Solutions bv are FDA-cleared AI-powered medical software.

Which medical specialties are primarily supported by each tool?

Autoplaque is designed to support both Cardiology and Radiology specialties. QFR is primarily focused on aiding cardiologists within the Cardiology specialty.